Would you like to discuss your research, specific methodological issues, or anything else with a real external expert, this is your chance.
Tuesday 14 November 2017 from 16.00 – 17.00 hrs. (Moeys A, route 96), dr. Marjanka Schmidt will visit the RIHS for a seminar. Title: Novel hereditary breast cancer variants: a new paradigm? You can see a brief CV below.
She is also available for discussions in an informal and almost private session.This so-called “Meet the Scientist” will take place from 14.30 until 15.30 hrs. If you would like to use this opportunity to speak to dr. Schmidt, please submit your question to Simone van Wezel by email (Simone.vanWezel@radboudumc.nl) at the latest by 10 November 2017. Also be prepared to give a short introduction to your question for the scientist and participants in the session (5 minutes).
Marjanka K Schmidt obtained her MSc and PhD degree at the Division of Nutrition and Epidemiology, Wageningen University, the Netherlands. Her PhD included a large micronutrient intervention study in semi-rural areas of Indonesia. In 2002, she came to the Netherlands Cancer Institute to work as a postdoc on breast cancer; specially on the survival of BRCA1/2 and CHEK2 c.1100delC mutation carriers. In 2004, she obtained a PhD certificate of Medical Biological Research in the field of Epidemiology. From 2008-2010 she undertook multiple working visits to University of Cambridge, UK, and Helsinki University Central Hospital, Finland. From 2010, she was an assistant professor and in October 2015 she became a group leader (associate professor). Her group works on molecular epidemiology of breast cancer and on ethical, legal and social issues in biobanking and cancer research. For more details: https://www.nki.nl/divisions/molecular-pathology/schmidt-m-group/
<< back to overview news items